Abilify® (aripiprazole) was approved by the U.S. Food and Drug Administration (FDA) in 2002 to treat patients suffering from depression, bipolar disorder, schizophrenia, and Tourette syndrome.
The drug has proved a success for its manufacturers, generating billions of dollars in sales. However, reports show patients taking Abilify may face an increased risk of pathological behaviors, including compulsive gambling and hypersexuality.
If you or someone you love took Abilify and suffered from compulsive gambling or hypersexuality, our drug injury lawyers want to talk to you. You may be entitled to compensation, but your time to take legal action is limited. Our legal staff is ready to assist you—call or contact us online to let us help protect your legal rights.
Abilify balances serotonin and dopamine levels in patients’ brains. But research indicates Abilify may over-stimulate the reward system in the brain, causing those taking the drug to develop an impulse control disorder.
The British Journal of Psychology published a study that links taking Abilify to a potential increased risk of compulsive gambling–regardless of a patient’s prior history of gambling. And according to the National Institutes of Health, patients treated with Abilify may experience strong desires for sexual involvement beyond the scope of their typical behavior.
Consequences of pathological behaviors linked to Abilify may include:
Compulsive gambling and hypersexuality can cause damage that can last a lifetime. Our attorneys understand the sensitivity of your situation, and we’ll fight to help ensure your voice gets heard.
You’re not alone if you or a loved one developed compulsive behavior after taking Abilify. Our drug injury lawyers have the skills and resources to hold pharmaceutical companies accountable for their negligence, and we’ll fight to help you get compensation. Call or contact us online now for a free case review.
Abilify® is a registered trademark of Bristol-Myers Squibb and Otsuka America Pharmaceutical, and is used here only to identify the product in question.
This Lundy Law is not associated with, sponsored by, or affiliated with Bristol-Myers Squibb Company; The British Journal of Psychology; The National Institutes of Health; Otsuka America Pharmaceutical; Otsuka Pharmaceutical Co., Ltd.; or the U.S. Food and Drug Administration.